TrialAlimentary pharmacology & therapeutics2017

Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.

B G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.